Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Vopr Onkol ; 60(1): 94-5, 2014.
Article in Russian | MEDLINE | ID: mdl-24772624

ABSTRACT

Antifibrinolytic drug epsilon-aminocaproic acid as a therapeutic form (5% solution in saline) was tested for antitumor activity in the autochthonous subcutaneous tumors of mice, induced by benzo (a) pyrene, in monotherapy mode (instead animals received drinking water) and in combination with cyclophosphamide, which was administered once intraperitoneally in the dose of 200 mg/kg. In the control groups, treated with drinking water and saline solution instead of water, there was no stabilization and reduction in tumor volume, while in the groups receiving epsilon-aminocaproic acid, cyclophosphamide and their combination statistically significantly in comparison with the control groups there was increased the proportion of tumors with not changed or reduced volume; epsilon-aminocaproic acid enhanced the antitumor effect of cyclophosphamide. The data obtained are for further study of the antitumor effect of epsilon-aminocaproic acid.


Subject(s)
Aminocaproic Acid/pharmacology , Antineoplastic Agents/pharmacology , Cyclophosphamide/pharmacology , Sarcoma, Experimental/drug therapy , Aminocaproic Acid/administration & dosage , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Benzo(a)pyrene , Carcinogens , Cyclophosphamide/administration & dosage , Drug Administration Schedule , Drug Screening Assays, Antitumor , Female , Mice , Sarcoma, Experimental/chemically induced , Treatment Outcome
2.
Vopr Onkol ; 60(4): 514-6, 2014.
Article in Russian | MEDLINE | ID: mdl-25552075

ABSTRACT

Previously it was found that sodium fluoroacetate (SF) inhibited the growth of the Ehrlich cancer by means of monotherapy and enhanced the antitumor effect of cyclophosphamide (CP) in experiments with autochthonous subcutaneous tumors induced by benzo (a) pyrene. In this study a comparison of the antitumor activity of SF and metformin showed that both substances did not have significant effect in monotherapy but enhanced the effect of CP, increasing the percentage of tumors with the same or reduced volume. Besides, SF, unlike metformin increased the average duration of effect. The data obtained promoted further study of the mechanism of the antitumor effect of SF and the search effective combination with already known antitumor drugs.


Subject(s)
Antineoplastic Agents/pharmacology , Cyclophosphamide/pharmacology , Fluoroacetates/pharmacology , Metformin/pharmacology , Sarcoma, Experimental/drug therapy , Animals , Drug Synergism , Mice , Mice, Inbred Strains , Time Factors
3.
Vopr Onkol ; 59(1): 89-93, 2013.
Article in Russian | MEDLINE | ID: mdl-23814832

ABSTRACT

Ninety female SHR mice were subcutaneously injected with a single dose of 2 mg benzo(a)pyrene (BaP) dissolved in 0.2 ml of vegetable oil. Since the next day after BaP injection mice were started to treat with mitochondria-targeted antioxidant SkQ1 at the doses of 5 and 50 nmol/kg/day in drinking water. Control animals received tap water. Study was finished by 358th day. Number of tumor-bearing mice increased in all groups exposed to BaP but retarded since 20th week in SkQ1-treated groups in comparison with control. Maximal tumor volume gain was observed in control mice resulting in premature death. By the 30th week of study only 20% of control animals survived, whereas SkQ1 treatment increased survival up to 30% at the dose of 5 nmol and 40% at the dose of 50 nmol. By the 40th week mean tumor volume in 5 and 50 nmol SkQ1-treated mice was 13 and 21 cm3 respectively, whereas in control--40 cm3. In SkQ1-treated mice pneumonia was observed rarely as compared with controls. It could be supposed, SkQ1 at the doses of 5 and 50 nmol/kg/day retarted BaP-induced soft tissue carcinogenesis in SHR mice.


Subject(s)
Anticarcinogenic Agents/pharmacology , Antioxidants/pharmacology , Cell Transformation, Neoplastic/drug effects , Plastoquinone/analogs & derivatives , Administration, Oral , Animals , Anticarcinogenic Agents/administration & dosage , Antioxidants/administration & dosage , Benzo(a)pyrene , Dose-Response Relationship, Drug , Drinking Water , Female , Mice , Mitochondria/drug effects , Plastoquinone/administration & dosage , Plastoquinone/pharmacology , Time Factors , Treatment Outcome
4.
Vopr Onkol ; 59(6): 777-80, 2013.
Article in Russian | MEDLINE | ID: mdl-24624791

ABSTRACT

Due to biochemical characteristics of toxic action of fluoroacetate on energetics and metabolism of cells, including tumor cells, it was interesting to testify sodium fluoroacetate (SFA) for its antitumor activity in vivo. We have estimated that SFA significantly inhibits growth of Ehrlich tumor carcinoma. In experiments with autochthonous induced by benzo[a]pyrene subcutaneous tumors, SFA was not active in monotherapy regime, though potentiated antitumor effect of cyclophosphamide, significantly increasing the relative number of mice with stabilized or decreased tumor volume as well as the duration of this effect. The data obtained render basis for additional studies of mechanism of antitumor effect of SFA.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Carcinoma, Ehrlich Tumor/drug therapy , Cyclophosphamide/pharmacology , Fluoroacetates/pharmacology , Sarcoma, Experimental/drug therapy , Animals , Antineoplastic Agents/pharmacology , Benzo(a)pyrene , Carcinoma, Ehrlich Tumor/chemically induced , Drug Synergism , Female , Mice , Treatment Failure , Treatment Outcome
5.
Vopr Onkol ; 58(2): 243-7, 2012.
Article in Russian | MEDLINE | ID: mdl-22774532

ABSTRACT

10 months old mice receiving SSH&H with daily food increased the lifespan in comparison to the control group. The maximal lifespan was increased by 1,6 months. For the long-living 10% group the mean lifespan increased by 8,7% compared to the control group (p<0,05). The mammary gland neoplasia rate was the same in both groups. The mean latent tumor development period duration, number and size of the tumors were also similar. There was a tendency to lower lung metastases rate in the experimental group. The cumulative neoplastic frequency curve for the experimental group was shifted to the right in comparison to the control group curve giving evidence to the inhibitory effect of SSH&H on the neoplastic rate in transgenic mice with HER-2/neu mutation.


Subject(s)
Anticarcinogenic Agents/pharmacology , Lung Neoplasms/prevention & control , Mammary Neoplasms, Animal/pathology , Mammary Neoplasms, Animal/prevention & control , Mutation , Receptor, ErbB-2/genetics , Animals , Female , Food Additives/pharmacology , Lung Neoplasms/secondary , Mammary Neoplasms, Animal/genetics , Mammary Neoplasms, Experimental/pathology , Mammary Neoplasms, Experimental/prevention & control , Mice , Mice, Transgenic
7.
Vopr Onkol ; 58(4): 549-53, 2012.
Article in Russian | MEDLINE | ID: mdl-23607214

ABSTRACT

Sixty one male 129/Sv mice were exposed to a single intraperitoneal injection of 1 g per kilo of urethane dissolved in 0.9% normal saline. Starting the next day from the injection the study group mice were given 1200 mg metformin per liter of drinking water 5 days a week for 26 weeks. The control group mice received pure drinking water. Six months after the urethane treatment the mice were killed and the morphology samples were taken. Twenty five of 31 (96.7%) control group mice developed tumors (lung adenomas and thymic lymphomas), while tumor development was observed in 25 of 31 (80.7%; p<0.05) mice exposed to metformin. Solid or trabecular lung adenomas developed in 90% of the control group mice and in 77% of the metformin group mice (p=0.119). Therefore, it is a first evidence of tumor-inhibitory effect of metformin in mice.


Subject(s)
Adenoma/prevention & control , Anticarcinogenic Agents/pharmacology , Lung Neoplasms/prevention & control , Lymphoma/prevention & control , Metformin/pharmacology , Thymus Neoplasms/prevention & control , Adenoma/chemically induced , Administration, Oral , Animals , Anticarcinogenic Agents/administration & dosage , Carcinogens/administration & dosage , Cell Transformation, Neoplastic , Drug Administration Schedule , Injections, Intraperitoneal , Lung Neoplasms/chemically induced , Lymphoma/chemically induced , Male , Metformin/administration & dosage , Mice , Thymus Neoplasms/chemically induced , Urethane/administration & dosage
8.
Vopr Onkol ; 55(5): 598-602, 2009.
Article in Russian | MEDLINE | ID: mdl-20020656

ABSTRACT

Such biological parameters as tumor volume, Ki-67 and p53, which characterize the development of ascites and solid tumor of Ehrlich were evaluated. The kinetic curve of growth of ascites tumor was S-shaped (Gomperts) while that of the solid one--cubic (Speer-Retsky). Ki-67 expression level was found to be in cyclic correlation with duration (3 and 6 day intervals) which might be worth considering when working out therapeutic procedure. Moreover, no increase in cell death was observed when tumor growth slowed down.


Subject(s)
Ascites/pathology , Biomarkers, Tumor/analysis , Carcinoma, Ehrlich Tumor/pathology , Animals , Ascites/metabolism , Ascites/physiopathology , Carcinoma, Ehrlich Tumor/chemistry , Carcinoma, Ehrlich Tumor/physiopathology , Female , Ki-67 Antigen/analysis , Kinetics , Mice , Time Factors , Tumor Suppressor Protein p53/analysis
9.
Adv Gerontol ; 15: 80-90, 2004.
Article in Russian | MEDLINE | ID: mdl-15754958

ABSTRACT

The effect of new antidiabetic drug Diabenol [9-diethylaminoethyl-2,3-dihydroimidazo-(1,2alpha) benzimidazol dihydrochloride] on life span and spontaneous tumor incidence in NMRI and transgenic HER-2/neu mice was studied. Female NMRI and transgenic HER-2/neu mice were given diabenol with drinking water (0.1 mg/l=approx. 10 mg/kg of b.w.) 5 times a week since the age of 2 months until natural death. The treatment with the drug failed influence body weight gain dynamics, food and water consumption and the body temperature in NMRI mice. Diabenol treatment slowed down age-related disturbances in estrous function and increased life span of all and 10% most long-living NMRI mice. The treatment with diabenol inhibited spontaneous tumor incidence (mammary gland and lymphomas mainly) and increased the mammary tumor latency. Dibenol treatment slowed down age-related changes in estrous function in HER-2/neu mice, failed influence survival of these mice and slightly inhibited the incidence and decreased the size of mammary adenocarcinoma metastases into the lung. Thus, long-term treatment with diabenol is safe and non-toxic in mice. The drug increases survival and inhibits spontaneous carcinogenesis in mice


Subject(s)
Adenocarcinoma/prevention & control , Benzimidazoles/therapeutic use , Hypoglycemic Agents/therapeutic use , Longevity/drug effects , Lymphoma/prevention & control , Mammary Neoplasms, Experimental/prevention & control , Adenocarcinoma/pathology , Aging/drug effects , Animals , Benzimidazoles/pharmacology , Estrous Cycle/drug effects , Female , Hypoglycemic Agents/pharmacology , Lymphoma/pathology , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Inbred Strains , Mice, Transgenic , Neoplasm Metastasis , Receptor, ErbB-2/genetics , Survival Analysis , Time Factors
10.
Vopr Onkol ; 50(5): 562-6, 2004.
Article in Russian | MEDLINE | ID: mdl-15715097

ABSTRACT

Diabenol, a new Russian antidiabetic drug, was used to investigate its effect on 1,2-dimethylhydrazine (DMH)-induced carcinogenesis in rat large gut. Five doses of 21 mg/kg DMH were injected at an interval of one week. Administration of 10 mg/kg diabenol with drinking water had no effect on either body mass or feed and water consumption. Yet, it was followed by a significant decrease in tumor incidence (4.22 vs. 5.77 tumors per tumor-bearers), frequency of neoplasms in the ascending colon (40.0% vs. 89.5%) and in their number (0.60% vs. 1.63 tumors per rat in a group). In the other groups, those indices tended to be still lower. Another tendency characteristic of the experimental group was a significantly high percentage of exophytic tumors (76.3% as compared with 50% in control) consisting of well-differentiated cells (47.4% and 14.7%, respectively) and with predominantly shallow invasion into the gut wall. Our results suggest the ability of the drug to inhibit DMH-induced carcinogenesis in the rat large gut.


Subject(s)
Antineoplastic Agents/pharmacology , Colonic Neoplasms/prevention & control , 1,2-Dimethylhydrazine , Animals , Colonic Neoplasms/chemically induced , Hypoglycemic Agents/pharmacology , Male , Rats
11.
Vopr Onkol ; 48(6): 700-2, 2002.
Article in Russian | MEDLINE | ID: mdl-12530267

ABSTRACT

Susceptibility to benz(a)pyrene (BP) has been compared between wild and knockout p53 homo- and heterozygous FVB/N, C57BL/6 and NMRI line mice. Each group included 34-80 animals. Each animal was injected 2 mg BP, s.c., in sunflower oil solution. The animals were followed up for 24 weeks. Fibrosarcomas arose at the site of injection in: wild FVB/N line mice--93%; FVB/N heterozygous--100%; p53 homozygous knockout--95%; C57B1/6--84%, and NMRI mice--83%. Mean latent period was 68, 66, 69, 112 and 109 days, respectively. Hence, FVB/N line mice developed tumors much earlier than C57B1/6 or NMRI did, suggesting their higher susceptibility to carcinogenic BP injection. No significant difference in susceptibility to carcinogen versus p53 expression was reported.


Subject(s)
Fibrosarcoma/genetics , Genes, p53 , Genetic Predisposition to Disease , Skin Neoplasms/genetics , Tumor Suppressor Protein p53/deficiency , Animals , Benzo(a)pyrene , Carcinogens , Fibrosarcoma/chemically induced , Heterozygote , Homozygote , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Skin Neoplasms/chemically induced , Tumor Suppressor Protein p53/genetics
12.
Vopr Onkol ; 46(3): 311-9, 2000.
Article in Russian | MEDLINE | ID: mdl-10976278

ABSTRACT

Fifty female CBA mice were given melatonin with drinking water (20 mg/l) for 5 consecutive days monthly, beginning from the age of 6 months, until natural death. Another 50 intact mice were used as controls. Melatonin failed to significantly influence body weight or food consumption. Age-related switching-off of estrus function was delayed, body temperature decreased. Somewhat decreased motor activity did not affect physical one or endurance. Increase in life span led to higher spontaneous tumor incidence. Another experiment using 20 animals of the same line showed melatonin to inhibit free-radical processes. A conclusion was drawn that caution should be exercised before melatonin is recommended for long-term administration as a geroprotector.


Subject(s)
Aging/drug effects , Free Radical Scavengers/pharmacology , Longevity/drug effects , Melatonin/pharmacology , Neoplasms, Experimental/physiopathology , Animals , Body Temperature/drug effects , Estrus/drug effects , Female , Free Radicals/metabolism , Mice , Mice, Inbred CBA , Motor Activity/drug effects , Neoplasms, Experimental/metabolism , Random Allocation
13.
Vopr Onkol ; 44(1): 68-73, 1998.
Article in Russian | MEDLINE | ID: mdl-9578735

ABSTRACT

Experiments involving the use of 1,2-dimethylhydrazine-induced colonic tumors in rats showed long-term treatment with a newly synthesized drug EDE-10g to inhibit an enzyme of enteric beta-glucuronidase, to suppress carcinogenesis and to prolong lifespan of animals.


Subject(s)
Anticarcinogenic Agents/pharmacology , Colonic Neoplasms/enzymology , Colonic Neoplasms/prevention & control , Glucuronidase/antagonists & inhibitors , 1,2-Dimethylhydrazine , Animals , Colonic Neoplasms/chemically induced , Colonic Neoplasms/pathology , Disease Models, Animal , Male , Rats , Survival Analysis
16.
Vopr Onkol ; 38(8): 942-9, 1992.
Article in Russian | MEDLINE | ID: mdl-1300804

ABSTRACT

Long-term treatment of rats and mice with riboxyn failed to reveal the carcinogenic effect of the drug. Chronic experiments showed the drug to improve resistance of the animals to intercurrent infections.


Subject(s)
Inosine Diphosphate/toxicity , Neoplasms, Experimental/chemically induced , Animals , Dose-Response Relationship, Drug , Female , Inosine Diphosphate/administration & dosage , Male , Mice , Neoplasms, Experimental/epidemiology , Neoplasms, Experimental/mortality , Rats , Sex Factors , Time Factors
18.
Vopr Onkol ; 25(6): 70-5, 1979.
Article in Russian | MEDLINE | ID: mdl-313623

ABSTRACT

When dissolved in water nitrosomorpholine induced in frogs Rana temporaria and aquarium fish adenomas and cancer, hemocytoblastosis, adenomatous polyps and adenocarcinomas of the intestine, mesenchymomas. A combined action of sodium nitrite and morpholine would induce the tumors concerned, but taken separately NN and M produced only a toxic effect. The morpholine nitration appears to proceed both endogenously and directly in water. It seems rational to use animals of the aqueous medium as an indicator of nitrosoamines and their precursors contamination of hydrosphere.


Subject(s)
Amphibians , Fishes , Morpholines/pharmacology , Neoplasms, Experimental/chemically induced , Nitroso Compounds/pharmacology , Animals , Anura , Dose-Response Relationship, Drug , Drug Synergism , Female , Male , Rana temporaria , Sodium Nitrite/pharmacology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...